GlassScriptPhysician profile
Jeffrey Badday
NPI 1154818201
$2,410.77
in general payments reported to CMS, 2019-2025
21 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.28 · 2021: $45.00 · 2022: $425 · 2023: $1,238 · 2024: $492 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $623.64 | 2022-2024 | Wavewriter Alpha Prime 16, Intracept |
| Vertos Medical, INC. | $371.95 | 2023-2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $270.34 | 2022-2023 | Intracept |
| Nevro Corp. | $187.96 | 2023-2024 | Senza |
| Painteq LLC | $176.60 | 2023 | Painteq |
| Amgen INC. | $95.24 | 2022 | |
| Medtronic, INC. | $76.12 | 2024 | Intellis Adaptivestim |
| Abbvie INC. | $72.93 | 2022-2025 | Qulipta |
| Averitas Pharma INC. | $68.42 | 2024 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.47 | 2025 | Relistor |
| Spr Therapeutics, INC | $66.00 | 2023 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $60.35 | 2024-2025 | Xtampza |
| Avanir Pharmaceuticals, INC. | $45.00 | 2021 | |
| Curonix LLC | $42.84 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merz Pharmaceuticals, LLC | $39.77 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $36.00 | 2023 | |
| Globus Medical, INC. | $31.21 | 2025 | Senza |
| Biotronik Nro, INC. | $24.42 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $20.96 | 2024 | Evoke |
| Stryker Corporation | $18.27 | 2025 | Optablate |
| Medtronic USA, INC. | $15.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Badday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.